Characterization of transgenic mice expressing apolipoprotein E4(C112R) and apolipoprotein E4(L28P; C112R)

被引:14
作者
Huber, G [1 ]
März, W
Martin, JR
Malherbe, P
Richards, JG
Sueoka, N
Ohm, T
Hoffmann, MM
机构
[1] F Hoffmann La Roche & Co Ltd, Preclin CNS Res, Pharma Div, CH-4070 Basel, Switzerland
[2] Univ Freiburg Klinikum, D-79106 Freiburg, Germany
[3] Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA
[4] Charite, Inst Anat, D-10098 Berlin, Germany
关键词
ApoE; behavior; motor activity; transgenic mice;
D O I
10.1016/S0306-4522(00)00341-9
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Apolipoprotein E (ApoE), which is genetically polymorphic, is a constituent of different lipoproteins. Two variants, ApoE4(C112R) and ApoE4(L28P; C112R) have been linked to the risk of developing Alzheimer's disease. Transgenic mice carrying ApoE4(C112R) (AD71) and ApoE4(L28P; C112R) (AD61) were generated and compared to wild-type mice. The use of glial fibrillary acidic protein as promoter led to transgene expression mainly in glial cells but also in neurons. Transgene protein levels were approximately three-and-a-half-fold that of endogenous ApoE in the glial fibrillary acidic protein-ApoE4(C112R) (AD71) and nearly twofold in the glial fibrillary acidic protein-ApoE4(L28P; C112R) (AD61) mouse Lines. Neither transgenic mouse differed from wild-type in cognitive tests at the age of approximately one-and a-half years. The locomotor activity of AD61 mice was similar to controls, whereas AD71 mice exhibited a clearly reduced level of motor activity. Immunohistological and biochemical brain protein analyses revealed no difference between strains. Thus, in the absence of morphological changes over-expression of ApoE4(C112R) on a background of endogenous mouse ApoE, may result in behavioral deficits while for the ApoE4(L28P; C112R) transgene higher expression might be required or some compensatory mechanisms might protect these animals from the behavioral abnormalities. (C) 2000 IBRO. Published by Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:211 / 218
页数:8
相关论文
共 37 条
[1]   APOLIPOPROTEIN-E SYNTHESIS IN HUMAN-KIDNEY, ADRENAL-GLAND, AND LIVER [J].
BLUE, ML ;
WILLIAMS, DL ;
ZUCKER, S ;
KHAN, SA ;
BLUM, CB .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1983, 80 (01) :283-287
[2]   APOLIPOPROTEIN-E ASSOCIATED WITH ASTROCYTIC GLIA OF THE CENTRAL NERVOUS-SYSTEM AND WITH NONMYELINATING GLIA OF THE PERIPHERAL NERVOUS-SYSTEM [J].
BOYLES, JK ;
PITAS, RE ;
WILSON, E ;
MAHLEY, RW ;
TAYLOR, JM .
JOURNAL OF CLINICAL INVESTIGATION, 1985, 76 (04) :1501-1513
[3]  
BOYLES JK, 1990, J BIOL CHEM, V265, P17805
[4]  
Cooper AD, 1997, J LIPID RES, V38, P2173
[5]   GENE DOSE OF APOLIPOPROTEIN-E TYPE-4 ALLELE AND THE RISK OF ALZHEIMERS-DISEASE IN LATE-ONSET FAMILIES [J].
CORDER, EH ;
SAUNDERS, AM ;
STRITTMATTER, WJ ;
SCHMECHEL, DE ;
GASKELL, PC ;
SMALL, GW ;
ROSES, AD ;
HAINES, JL ;
PERICAKVANCE, MA .
SCIENCE, 1993, 261 (5123) :921-923
[6]   APOLIPOPROTEIN-E POLYMORPHISM AND ATHEROSCLEROSIS [J].
DAVIGNON, J ;
GREGG, RE ;
SING, CF .
ARTERIOSCLEROSIS, 1988, 8 (01) :1-21
[7]  
DAWSON PA, 1986, J BIOL CHEM, V261, P5681
[8]   GENETIC-HETEROGENEITY OF APOLIPOPROTEIN-E AND ITS INFLUENCE ON PLASMA-LIPID AND LIPOPROTEIN LEVELS [J].
DEKNIJFF, P ;
VANDENMAAGDENBERG, AMJM ;
FRANTS, RR ;
HAVEKES, LM .
HUMAN MUTATION, 1994, 4 (03) :178-194
[9]   ABNORMAL INVIVO METABOLISM OF APOLIPOPROTEIN-E4 IN HUMANS [J].
GREGG, RE ;
ZECH, LA ;
SCHAEFER, EJ ;
STARK, D ;
WILSON, D ;
BREWER, HB .
JOURNAL OF CLINICAL INVESTIGATION, 1986, 78 (03) :815-821
[10]   Transgenic mouse models to study the role of APOE in hyperlipidemia and atherosclerosis [J].
Hofker, MH ;
van Vlijmen, BJM ;
Havekes, LM .
ATHEROSCLEROSIS, 1998, 137 (01) :1-11